However, retatrutide is still being studied, and its long-term safety and tolerability are not as well known as tirzepatide
Current long-term safety studies of biologics have limitations, including selection bias in clinical trials, limited sample sizes and follow-up durations, lack of standardized safety outcome definitions, and heterogeneity in real-world data
Add the fact that I flew out Friday night for a week in Italy (more on that later), and it's safe to say I had a rocky week
Lentusiasmo per questi farmaci C un grande entusiasmo tra gli addetti ai lavori (endocrinologi, internisti, obesiologi, medici specialisti in scienza dellalimentazione) perch finalmente anche lobesit, che una malattia cronica, ha a disposizione dei farmaci di grande efficacia, come da molti anni per il diabete e lipertensione arteriosa